BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16861609)

  • 1. Early decreases in plasma lipid transfer proteins during weight reduction.
    Tzotzas T; Dumont L; Triantos A; Karamouzis M; Constantinidis T; Lagrost L
    Obesity (Silver Spring); 2006 Jun; 14(6):1038-45. PubMed ID: 16861609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.
    Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
    Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans.
    Kujiraoka T; Nanjee MN; Oka T; Ito M; Nagano M; Cooke CJ; Takahashi S; Olszewski WL; Wong JS; Stepanova IP; Hamilton RL; Egashira T; Hattori H; Miller NE
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1653-9. PubMed ID: 12893687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A low-saturated-fat, low-cholesterol diet decreases plasma CETP activity and pre beta-HDL formation but does not affect cellular cholesterol efflux to plasma from type 1 diabetic patients.
    De Vries R; Beusekamp BJ; Kerstens MN; Groen AK; Van Tol A; Dullaart RP
    Scand J Clin Lab Invest; 2005; 65(8):729-37. PubMed ID: 16319046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O
    Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.
    Dullaart RP; Borggreve SE; Hillege HL; Dallinga-Thie GM
    Scand J Clin Lab Invest; 2008; 68(2):99-105. PubMed ID: 17852818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum cholesteryl ester transfer protein in obese children.
    Asayama K; Hayashibe H; Dobashi K; Uchida N; Nakane T; Kodera K; Shirahata A
    Obes Res; 2002 Jun; 10(6):439-46. PubMed ID: 12055319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome.
    Watts GF; Ji J; Chan DC; Ooi EM; Johnson AG; Rye KA; Barrett PH
    Clin Sci (Lond); 2006 Sep; 111(3):193-9. PubMed ID: 16700661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo.
    Ooi EM; Watts GF; Ji J; Rye KA; Johnson AG; Chan DC; Barrett PH
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):752-9. PubMed ID: 17121526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesteryl ester transfer protein in metabolic syndrome.
    Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
    Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
    Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
    Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V.
    Seiler S; Schlitt A; Jiang XC; Ulrich C; Blankenberg S; Lackner KJ; Girndt M; Werdan K; Buerke M; Fliser D; Heine GH
    Nephrol Dial Transplant; 2008 Nov; 23(11):3599-604. PubMed ID: 18503096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations.
    Dullaart RP; De Vries R; Scheek L; Borggreve SE; Van Gent T; Dallinga-Thie GM; Ito M; Nagano M; Sluiter WJ; Hattori H; Van Tol A
    Scand J Clin Lab Invest; 2004; 64(3):205-15. PubMed ID: 15222630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients.
    Lagrost L; Athias A; Herbeth B; Guyard-Dangremont V; Artur Y; Paille F; Gambert P; Lallemant C
    J Biol Chem; 1996 Aug; 271(32):19058-65. PubMed ID: 8702577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
    van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.
    Hajer GR; Dallinga-Thie GM; van Vark-van der Zee LC; Olijhoek JK; Visseren FL
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):870-7. PubMed ID: 18394022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women.
    Tzotzas T; Filippatos TD; Triantos A; Bruckert E; Tselepis AD; Kiortsis DN
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):477-82. PubMed ID: 17928209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipid transfer protein is present in human tear fluid.
    Jauhiainen M; Setälä NL; Ehnholm C; Metso J; Tervo TM; Eriksson O; Holopainen JM
    Biochemistry; 2005 Jun; 44(22):8111-6. PubMed ID: 15924430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults.
    Gugliucci A; Kotani K; Taing J; Matsuoka Y; Sano Y; Yoshimura M; Egawa K; Horikawa C; Kitagawa Y; Kiso Y; Kimura S; Sakane N
    Ann Nutr Metab; 2009; 54(3):197-201. PubMed ID: 19420913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
    Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.